ARCHIVES

VIB CIDAC contract Extended, No Gaps In CANCERGRAMS

This article is from The Cancer Letter archive.

Vol. 10 No. 24 | June 15, 1984

Download PDF Visit The Full Archive

Related Articles

Afinitor Increases Overall Survival To 3.5 Years in Phase III Trial

September 26, 2014

Tamoxifen Makes ER-Negative Breast Cancer Easier To Find

October 31, 2008

Three NCAB Members Say They Cannot Offer “Strong Endorsement” Of P-4 Trial.

June 15, 2007

NCI, Dept. of Veteran’s Affairs Sign Agreement On Clinical Trials Access

November 1, 1996

Broder To Leave In March; Sondik To Be Acting Director

January 27, 1995

Spending Measures Include Provisions On Ethics For NIH Extramural Scientists.

July 11, 2008